Skip to main navigation Skip to search Skip to main content
  • 3647
    Citations
20142025

Research activity per year

Personal profile

Research interests

Hepatitis C virus (HCV) is a major global health threat and kills around 300,000 peope each year. Still, there is no effective vaccine available.

After my PhD on HIV-1 vaccines, I pivoted my research line towards HCV. In 2022, together with collegues from Scripps Research Institute, we solved the structure of the HCV E1E2 spike. Now, we are using this structure to inform the design of novel HCV antigens. I also employ nanoparticle and mRNA strategies to further improve the immunogenicity of these candidates.

My team has developed a series of first and second generation stabilzied E1E2 antigens, which we have used to study the binding of HCV bispecific antibodies and to study human-induced HCV neutralizing antibodies.

We are currently using these antigens to decipher the humoral response in HCV-infected individuals and develop a clinically relevant HCV vaccine. For this we will employ mRNA and nanoparticle technology and we have started to pivot towards AI-based vaccine design.

Specialisation

My specialization lies in the use of computational design of envelope glycoproteins. This includes structure-based design and recently also AI-based approaches. Furthermore, throughout my PhD and postdoctoral research, I have used nanoparticles to develop experimental vaccines against HIV-1 and HCV.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics where Kwinten Sliepen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • BG505 SOSIP-I53-50NP

    Brouwer, P. J. M. (Contributor), Antanasijevic, A. (Contributor), Berndsen, Z. (Contributor), Yasmeen, A. (Contributor), Fiala, B. (Contributor), Bijl, T. P. L. (Contributor), Bontjer, I. (Contributor), Bale, J. B. (Contributor), Sheffler, W. (Contributor), Allen, J. D. (Contributor), Schorcht, A. (Contributor), Burger, J. A. (Contributor), Camacho, M. (Contributor), Ellis, D. (Contributor), Cottrell, C. A. (Contributor), Behrens, A.-J. (Contributor), Catalano, M. (Contributor), del Moral-Sánchez, I. (Contributor), Ketas, T. J. (Contributor), LaBranche, C. (Contributor), van Gils, M. J. (Contributor), Sliepen, K. (Contributor), Stewart, L. J. (Contributor), Crispin, M. (Contributor), Montefiori, D. C. (Contributor), Baker, D. (Contributor), Moore, J. P. (Contributor), Klasse, P. J. (Contributor), Ward, A. B. (Contributor), King, N. P. (Contributor) & Sanders, R. W. (Contributor), Protein Data Bank (PDB), 19 Jun 2019

    Dataset